Haemagglutinin-strain A(H1N1)
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Brand Names
- Afluria Tetra, Agriflu, FluLaval Tetra, Fluad, Fluad Pediatric, Fluviral, Fluzone, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra
- Generic Name
- Haemagglutinin-strain A(H1N1)
- DrugBank Accession Number
- DB15476
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Haemagglutinin-strain A (H1N1)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Panenza Suspension 15 mcg / 0.5 mL Intramuscular Sanofi Pasteur Inc. Not applicable Not applicable Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ADIMFLU Haemagglutinin-strain A(H1N1) (15 mcg/0.5ml) + Haemagglutinin-strain A(H3N2) (15 mcg/0.5ml) + Influenza virus type B (Victoria) (15 mcg/0.5ml) บริษัท ไบโอเนท - เอเชีย จำกัด จำกัด 2019-09-09 Not applicable Thailand Afluria Tetra Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL) Suspension Intramuscular Seqirus S.R.L. 2020-09-23 Not applicable Canada Afluria Tetra Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL) Suspension Intramuscular Seqirus S.R.L. 2019-10-25 Not applicable Canada Afluria Tetra Injektionssuspension in einer Fertigspritze Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (Victoria-like) (15 mcg) + Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (formaldehyde inactivated) (15 mcg) Injection, suspension Intramuscular Seqirus S.R.L. 2020-05-26 Not applicable Austria Agriflu Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (15 mcg) Suspension Intramuscular Seqirus S.R.L. 2010-10-04 2020-06-30 Canada
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Not Available Astrocytoma / Glioma / Oligodendroglioma 1 somestatus stop reason just information to hide Not Available Completed Not Available Inflammation / Iron Deficiency Anemia (IDA) 1 somestatus stop reason just information to hide Not Available Completed Basic Science Acquired Immune Deficiency Syndrome (AIDS) / Flu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections 1 somestatus stop reason just information to hide Not Available Completed Prevention Flu caused by Influenza 2 somestatus stop reason just information to hide Not Available Completed Prevention Heart Failure / Mamma Carcinoma 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension Intramuscular Suspension Intramuscular Suspension Intramuscular; Subcutaneous Injection, suspension Intramuscular; Subcutaneous Suspension Intradermal Suspension Intramuscular 15 mcg / 0.5 mL Injection - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at August 30, 2019 15:26 / Updated at November 30, 2021 07:50